96 related articles for article (PubMed ID: 18006057)
1. The clinical significance of activated lymphocytes in patients with myelodysplastic syndromes: a single centre study of 131 patients.
Meers S; Vandenberghe P; Boogaerts M; Verhoef G; Delforge M
Leuk Res; 2008 Jul; 32(7):1026-35. PubMed ID: 18006057
[TBL] [Abstract][Full Text] [Related]
2. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.
Boula A; Voulgarelis M; Giannouli S; Katrinakis G; Psyllaki M; Pontikoglou C; Markidou F; Eliopoulos GD; Papadaki HA
Clin Cancer Res; 2006 May; 12(10):3099-108. PubMed ID: 16707608
[TBL] [Abstract][Full Text] [Related]
3. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
4. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
Kiladjian JJ; Visentin G; Viey E; Chevret S; Eclache V; Stirnemann J; Bourhis JH; Chouaib S; Fenaux P; Caignard A
Haematologica; 2008 Mar; 93(3):381-9. PubMed ID: 18268282
[TBL] [Abstract][Full Text] [Related]
5. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome].
Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.
Epling-Burnette PK; Painter JS; Rollison DE; Ku E; Vendron D; Widen R; Boulware D; Zou JX; Bai F; List AF
Leukemia; 2007 Apr; 21(4):659-67. PubMed ID: 17301813
[TBL] [Abstract][Full Text] [Related]
7. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
[TBL] [Abstract][Full Text] [Related]
8. [Study on the burden of abnormal hematopoietic clone of the patients with myelodysplastic syndromes and its implications].
Wang HQ; Shao ZH; Shi J; Cao YR; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):473-6. PubMed ID: 16383238
[TBL] [Abstract][Full Text] [Related]
9. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
[TBL] [Abstract][Full Text] [Related]
10. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
Wu L; Li X; Chang C; Ying S; He Q; Pu Q
Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
[TBL] [Abstract][Full Text] [Related]
11. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of lymphocyte subpopulations and cytokine-producing activity of blood cells in patients with primary myelodysplastic syndrome].
Gritsaev SV; Rozanova OE; Abdulkadyrov KM; Bubnova LN; Tiranova SA
Vopr Onkol; 2005; 51(5):563-6. PubMed ID: 16756011
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.
Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q
Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic studies in myelodysplastic syndrome].
Molnár L; Burger T; Schmelczer M; Fábián G
Orv Hetil; 1991 Oct; 132(42):2299-302. PubMed ID: 1945366
[TBL] [Abstract][Full Text] [Related]
20. The role of T-cells in the pathogenesis of myelodysplastic syndromes: passengers and drivers.
Fozza C; Longinotti M
Leuk Res; 2013 Feb; 37(2):201-3. PubMed ID: 23218025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
